Home/Filings/4/0001209191-18-048858
4//SEC Filing

Haasner Dirk 4

Accession 0001209191-18-048858

CIK 0001636651other

Filed

Aug 28, 8:00 PM ET

Accepted

Aug 29, 6:24 PM ET

Size

9.3 KB

Accession

0001209191-18-048858

Insider Transaction Report

Form 4
Period: 2018-08-27
Haasner Dirk
SVP, Global Regulatory Affairs
Transactions
  • Award

    Employee Stock Option (right to buy)

    2018-08-27+22,50022,500 total
    Exercise: $6.40Exp: 2028-08-27Common Stock (22,500 underlying)
Footnotes (1)
  • [F1]The option, representing a right to purchase a total of 22,500 shares becomes exercisable in two equal annual installments beginning on August 27, 2019, subject to the Reporting Person's continued service through each such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001704660

Filing Metadata

Form type
4
Filed
Aug 28, 8:00 PM ET
Accepted
Aug 29, 6:24 PM ET
Size
9.3 KB